Digestive Diseases and Sciences

, Volume 59, Issue 2, pp 358–364 | Cite as

Chemokine–Chemokine Receptor CCL2–CCR2 and CX3CL1–CX3CR1 Axis May Play a Role in the Aggravated Inflammation in Primary Biliary Cirrhosis

  • Motoko Sasaki
  • Masami Miyakoshi
  • Yasunori Sato
  • Yasuni Nakanuma
Original Article


Background and Aims

Senescent cells can alter local tissue environments by secretion of various senescence-associated secretory phenotypes (SASP), such as cytokines and chemokines. Given senescent biliary epithelial cells (BECs) in damaged small bile ducts in primary biliary cirrhosis (PBC) show increased expression of chemokines CCL2 and CX3CL1 as SASP, we further examined an involvement of CCL2/CCR2 and CX3CL1/CX3CR1 systems in the pathogenesis of PBC.


We examined immunohistochemically the expression of CCR2, CX3CR1, CCL2 and CX3CL1 in livers taken from the patients with PBC (n = 45) and control livers (n = 78), such as chronic viral hepatitis (CVH; n = 39). CCR2 or CX3CR1-expressing cells were characterized by double immunofluorescence with CD3, CD4, CD8, CD56 or CD68.


CCR2 is expressed in round cells, epithelioid cells and dendritic cells and most CCR2-positive cells were CD68-positive. Infiltration of CCR2-positive cells in the intraepithelial layer or around small bile ducts was significantly more extensive in PBC than CVH and normal liver (p < 0.05) and was significantly correlated with the expression of CCL2 in BECs (p < 0.01). Most CX3CR1-expressing inflammatory cells were CD3-positive T cells (CD8 > CD4). Infiltration of CX3CR1-positive cells in the intraepithelial layer and around small bile ducts was significantly more extensive in PBC than control livers (p < 0.05) and was significantly correlated with the expression of CX3CL1 in BECs (p < 0.05).


CCL2 and CX3CL1 produced by senescent BECs may promote infiltration of corresponding CCR2 and CX3CR1-expressing cells and further aggravate inflammation in bile duct lesion in PBC.


Chemokine CCR2 CX3CR1 Primary biliary cirrhosis Cellular senescence Senescence-associated secretory phenotype 


  1. 1.
    Gershwin ME, Mackay IR, Sturgess A, Coppel RL. Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol. 1987;138:3525–3531.PubMedGoogle Scholar
  2. 2.
    Kaplan M. Primary biliary cirrhosis. New Engl J Med. 1996;335:1570–1580.PubMedCrossRefGoogle Scholar
  3. 3.
    Portmann B, Nakanuma Y. Diseases of the bile ducts. In: Ishak K, Scheuer P, Anthony P, MacSween R, Burt A, BC P, eds. Pathology of the Liver. London: Churchill Livingstone; 2001:435–506.Google Scholar
  4. 4.
    Nakanuma Y, Ohta G. Histometric and serial section observations of the intrahepatic bile ducts in primary biliary cirrhosis. Gastroenterology. 1979;76:1326–1332.PubMedGoogle Scholar
  5. 5.
    Sasaki M, Ikeda H, Yamaguchi J, Nakada S, Nakanuma Y. Telomere shortening in the damaged small bile ducts in primary biliary cirrhosis reflects ongoing cellular senescence. Hepatology. 2008;48:186–195.PubMedCrossRefGoogle Scholar
  6. 6.
    Sasaki M, Ikeda H, Haga H, Manabe T, Nakanuma Y. Frequent cellular senescence in small bile ducts in primary biliary cirrhosis: a possible role in bile duct loss. J Pathol. 2005;205:451–459.PubMedCrossRefGoogle Scholar
  7. 7.
    Sasaki M, Ikeda H, Nakanuma Y. Activation of ATM signaling pathway is involved in oxidative stress-induced expression of mito-inhibitory p21(WAF1/Cip1) in chronic non-suppurative destructive cholangitis in primary biliary cirrhosis: an immunohistochemical study. J Autoimmun. 2008;31:73–78.PubMedCrossRefGoogle Scholar
  8. 8.
    Sasaki M, Ikeda H, Sato Y, Nakanuma Y. Decreased expression of Bmi1 is closely associated with cellular senescence in small bile ducts in primary biliary cirrhosis. Am J Pathol. 2006;169:831–845.PubMedCrossRefGoogle Scholar
  9. 9.
    Lunz JG 3rd, Contrucci S, Ruppert K, et al. Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection: increased expression of p21(WAF1/Cip1) as a disease marker and the influence of immunosuppressive drugs. Am J Pathol. 2001;158:1379–1390.PubMedCrossRefGoogle Scholar
  10. 10.
    Krizhanovsky V, Yon M, Dickins RA, et al. Senescence of activated stellate cells limits liver fibrosis. Cell. 2008;134:657–667.PubMedCentralPubMedCrossRefGoogle Scholar
  11. 11.
    Plentz RR, Park YN, Lechel A, et al. Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis. Hepatology. 2007;45:968–976.PubMedCrossRefGoogle Scholar
  12. 12.
    Acosta JC, O’Loghlen A, Banito A, et al. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell. 2008;133:1006–1018.PubMedCrossRefGoogle Scholar
  13. 13.
    Kuilman T, Michaloglou C, Vredeveld LC, et al. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell. 2008;133:1019–1031.PubMedCrossRefGoogle Scholar
  14. 14.
    Wajapeyee N, Serra RW, Zhu X, Mahalingam M, Green MR. Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell. 2008;132:363–374.PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    Shelton DN, Chang E, Whittier PS, Choi D, Funk WD. Microarray analysis of replicative senescence. Curr Biol. 1999;9:939–945.PubMedCrossRefGoogle Scholar
  16. 16.
    Coppe JP, Patil CK, Rodier F, et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 2008;6:2853–2868.PubMedCrossRefGoogle Scholar
  17. 17.
    Sasaki M, Miyakoshi M, Sato Y, Nakanuma Y. Modulation of the microenvironment by senescent biliary epithelial cells may be involved in the pathogenesis of primary biliary cirrhosis. J Hepatol. 2010;53:318–325.PubMedCrossRefGoogle Scholar
  18. 18.
    Nakanuma Y, Sasaki M. Expression of blood-group-related antigens in the intrahepatic biliary tree and hepatocytes in normal livers and various hepatobiliary diseases. Hepatology. 1989;10:174–178.PubMedCrossRefGoogle Scholar
  19. 19.
    Ludwig J. Small-duct primary sclerosing cholangitis. Semin Liver Dis. 1991;11:11–17.PubMedCrossRefGoogle Scholar
  20. 20.
    Desmet V, Gerber M, Hoofnagle J, Manns M, Scheuer P. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 1994;19:1513–1520.PubMedCrossRefGoogle Scholar
  21. 21.
    Degre D, Lemmers A, Gustot T, et al. Hepatic expression of CCL2 in alcoholic liver disease is associated with disease severity and neutrophil infiltrates. Clin Exp Immunol. 2012;169:302–310.PubMedCentralPubMedCrossRefGoogle Scholar
  22. 22.
    Miura K, Yang L, van Rooijen N, Ohnishi H, Seki E. Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2. Am J Physiol Gastrointest Liver Physiol. 2012;302:G1310–G1321.PubMedCrossRefGoogle Scholar
  23. 23.
    Viebahn CS, Benseler V, Holz LE, et al. Invading macrophages play a major role in the liver progenitor cell response to chronic liver injury. J Hepatol. 2010;53:500–507.PubMedCrossRefGoogle Scholar
  24. 24.
    Chiba M, Sasaki M, Kitamura S, Ikeda H, Sato Y, Nakanuma Y. Participation of bile ductular cells in the pathological progression of non-alcoholic fatty liver disease. J Clin Pathol. 2011;64:564–570.PubMedCrossRefGoogle Scholar
  25. 25.
    Ohanna M, Giuliano S, Bonet C, et al. Senescent cells develop a PARP-1 and nuclear factor-{kappa}B-associated secretome (PNAS). Genes Dev. 2011;25:1245–1261.PubMedCrossRefGoogle Scholar
  26. 26.
    Shimoda S, Harada K, Niiro H, et al. CX3CL1 (fractalkine): a signpost for biliary inflammation in primary biliary cirrhosis. Hepatology. 2010;51:567–575.PubMedCentralPubMedCrossRefGoogle Scholar
  27. 27.
    Isse K, Harada K, Zen Y, et al. Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts. Hepatology. 2005;41:506–516.PubMedCrossRefGoogle Scholar
  28. 28.
    Zhang W, Ono Y, Miyamura Y, Bowlus CL, Gershwin ME, Maverakis E. T cell clonal expansions detected in patients with primary biliary cirrhosis express CX3CR1. J Autoimmun. 2011;37:71–78.PubMedCrossRefGoogle Scholar
  29. 29.
    de Vos AF, Pater JM, van den Pangaart PS, de Kruif MD, van ‘t Veer C, van der Poll Y. In vivo lipopolysaccharide exposure of human blood leukocytes induces cross-tolerance to multiple TLR ligands. J Immunol. 2009;183:533–542.PubMedCrossRefGoogle Scholar
  30. 30.
    van ‘t Veer C, van den Pangaart PS, van Zoelen MA et al. Induction of IRAK-M is associated with lipopolysaccharide tolerance in a human endotoxemia model. J Immunol. 2007;179:7110–7120.Google Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Motoko Sasaki
    • 1
  • Masami Miyakoshi
    • 1
  • Yasunori Sato
    • 1
  • Yasuni Nakanuma
    • 1
  1. 1.Department of Human PathologyKanazawa University Graduate School of MedicineKanazawaJapan

Personalised recommendations